- Nalu provides solutions for chronic neuropathic pain
- Runway Growth Capital provide senior term loans of $10 million to $75 million to fast-growing companies based in the US and Canada
- David Spreng leads Runway Growth Capital
Runway Growth Capital has provided a $45 million term loan to Carlsbad, California-based Nalu Medical, a medical device company.
Nalu provides solutions for chronic neuropathic pain.
The capital will be used for expansion and growth.
“We are grateful for the ability to partner with an innovative medical device company providing a much needed alternative to opioids to treat chronic pain,” said Igor DaCruz, a managing director at life sciences at Runway, in a statement.
Led by David Spreng, Runway Growth Capital provide senior term loans of $10 million to $75 million to fast-growing companies based in the U.S. and Canada.
The Nalu neurostimulation system transmits gentle electrical pulses to the nervous system to modulate pain signals before they get to the brain. The system was designed to address major unmet needs in the treatment of chronic neuropathic pain and represents a transformative new opportunity for patients and physicians.